Novadaq Technologies, a developer of medical imaging systems and image-guided therapies for the operating room, will launch the Pinpoint endoscopic imaging system at the annual meeting of the American College of Chest Physicians (ACCP) in Chicago next week.

The Pinpoint device is designed to perform white light bronchoscopy, autofluorescence and narrow band imaging, according to the Mississauga, Ontario-based company.

Novadaq said the ACCP evidence-based practice guidelines now recommend the use of autofluorescence bronchoscopy for the localization of certain lung cancers, for guiding endoluminal therapies and as a surveillance tool in patients with pre-invasive disease.